MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

A Long-Living Human Tissue Engineered Nigrostriatal Pathway as a Testbed to Study Parkinson’s Disease

D. Chouhan, A. Bello, K. Cullen, J. Duda (Philadelphia, USA)

Meeting: 2025 International Congress

Keywords: Aging, Dopaminergic neurons, Parkinson’s

Category: Parkinson's Disease: Pathophysiology / molecular mechanisms of disease

Objective: To create a three dimensional (3D) long-living model of human tissue-engineered nigrostriatal pathway (TE-NSP) comprised of discrete somatic and axonal compartments recapitulating the native pathway.

Background: With the rising prevalence of Parkinson’s disease (PD) and the complexity associated with heterogeneity in PD, we need reliable tools to study pathophysiology changes at cellular and molecular levels. Although tissue engineered constructs are well-established in the field of regenerative medicine and drug discovery, maintaining long-lived neuronal culture conditions without glial support is very challenging. Here, we sought to build a long-living model of TE-NSP based on clinical criteria that recapitulates the human NSP.  The TE-NSP model holds great potential as a testbed to map out and understand chronic pathological events occurring in human DA neurons, thereby providing insight into human pathophysiology.

Method: TE-NSPs were fabricated using methacrylated hyaluronic acid (MeHA) hydrogel encasement filled with collagen/laminin solution that were used to seed two types of neuronal aggregates, namely, human iPSC-derived dopaminergic (DA) neurons and striatal medium spiny neurons (MSNs). These TE-NSPs were characterized for axonal growth, viability and histological analysis up to 6 months.

Results: TE-NSPs fabricated with an aggregate containing 220,000 human DA neurons demonstrated a maximum length of 2.5 and 3 cm in the absence and presence of MSNs respectively. The DA neurons in the TE-NSPs exhibited survival up to 6 months in vitro with robust dense TH+ axonal tracts and 90% cell viability. In contrast, the neuronal aggregates cultured on 2D surface showed a significantly slower growth rate achieving a maximum length of 0.5 cm and survival for 4 weeks signifying that the 3D hydrogel microcolumns provide a platform for long-term survival of dopaminergic neuronal cultures.

Conclusion: Recapitulating some aspects of neurodegeneration in human neuron systems is currently an unmet need, including the effects of aging. Therefore, a long-living 3D human TE-NSP model with two discrete neuronal populations holds great potential in understanding the role of aging disease mechanisms on the underlying neurodegenerative events associated with PD.

To cite this abstract in AMA style:

D. Chouhan, A. Bello, K. Cullen, J. Duda. A Long-Living Human Tissue Engineered Nigrostriatal Pathway as a Testbed to Study Parkinson’s Disease [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/a-long-living-human-tissue-engineered-nigrostriatal-pathway-as-a-testbed-to-study-parkinsons-disease/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/a-long-living-human-tissue-engineered-nigrostriatal-pathway-as-a-testbed-to-study-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley